2012 annual financial data
PharmaCyte Biotech 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -389.57%.
Operating income was -1,949,000 USD and net income was -1,899,000 USD.
Operating cash flow was -259,289 USD.
Get free PharmaCyte Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 66,558 USD
- Operating income
- -1,949,000 USD
- Net income
- -1,899,000 USD
- Operating cash flow
- -259,289 USD